284 related articles for article (PubMed ID: 10376237)
1. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
Sheikh JI; Swales PJ
Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
[TBL] [Abstract][Full Text] [Related]
2. Panic disorder: long-term pharmacotherapy and discontinuation.
Rickels K; Schweizer E
J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
[TBL] [Abstract][Full Text] [Related]
3. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
Keller MB; Lavori PW; Goldenberg IM; Baker LA; Pollack MH; Sachs GS; Rosenbaum JF; Deltito JA; Leon A; Shear K
J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
[TBL] [Abstract][Full Text] [Related]
4. Growing placebo response rate: the problem in recent therapeutic trials?
Uhlenhuth EH; Matuzas W; Warner TD; Thompson PM
Psychopharmacol Bull; 1997; 33(1):31-9. PubMed ID: 9133749
[TBL] [Abstract][Full Text] [Related]
5. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
Pollack MH; Otto MW; Sachs GS; Leon A; Shear MK; Deltito JA; Keller MB; Rosenbaum JF
J Affect Disord; 1994 Apr; 30(4):273-81. PubMed ID: 8014326
[TBL] [Abstract][Full Text] [Related]
6. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Rickels K; Schweizer E; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
Taylor CB; Hayward C; King R; Ehlers A; Margraf J; Maddock R; Clark D; Roth WT; Agras WS
J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
[TBL] [Abstract][Full Text] [Related]
8. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
Schweizer E; Rickels K; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
[TBL] [Abstract][Full Text] [Related]
9. Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.
Br J Psychiatry; 1992 Feb; 160():191-202; discussion 202-5. PubMed ID: 1540759
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.
Nair NP; Bakish D; Saxena B; Amin M; Schwartz G; West TE
Anxiety; 1996; 2(4):192-8. PubMed ID: 9160622
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
León CA; De Arango MV; Arevalo W; Calvo A; Montoya A; León A
Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):59-72. PubMed ID: 2073024
[TBL] [Abstract][Full Text] [Related]
12. Experimental procedures and the placebo response.
Harv Ment Health Lett; 1998 Oct; 15(4):6. PubMed ID: 9755656
[No Abstract] [Full Text] [Related]
13. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
Schweizer E; Patterson W; Rickels K; Rosenthal M
Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
[TBL] [Abstract][Full Text] [Related]
14. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis.
Boyer W
Int Clin Psychopharmacol; 1995 Mar; 10(1):45-9. PubMed ID: 7622804
[TBL] [Abstract][Full Text] [Related]
15. A 15-year follow-up study of patients with panic disorder.
Andersch S; Hetta J
Eur Psychiatry; 2003 Dec; 18(8):401-8. PubMed ID: 14680716
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
Andersch S; Rosenberg NK; Kullingsjö H; Ottosson JO; Bech P; Bruun-Hansen J; Hanson L; Lorentzen K; Mellergård M; Rasmussen S
Acta Psychiatr Scand Suppl; 1991; 365():18-27. PubMed ID: 1862730
[TBL] [Abstract][Full Text] [Related]
17. Drug treatment of panic disorder.
Rosenberg R
Pharmacol Toxicol; 1993 Jun; 72(6):344-53. PubMed ID: 8103214
[TBL] [Abstract][Full Text] [Related]
18. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
Deltito JA; Argyle N; Klerman GL
J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
[TBL] [Abstract][Full Text] [Related]
19. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
Rosenberg R; Bech P; Mellergård M; Ottosson JO
Acta Psychiatr Scand Suppl; 1991; 365():46-52. PubMed ID: 1862734
[TBL] [Abstract][Full Text] [Related]
20. A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression.
Leon AC; Shear MK; Klerman GL; Portera L; Rosenbaum JF; Goldenberg I
J Clin Psychopharmacol; 1993 Oct; 13(5):327-31. PubMed ID: 8227491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]